Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Spleen and kidney" does not identify a single molecular target, such as a protein, receptor, or enzyme, but instead refers to a pair of anatomical organs or a clinical syndrome in Traditional Chinese Medicine (TCM). In pharmacology, the term is most frequently encountered in the context of "Spleen and Kidney Deficiency," a pathological pattern used in TCM to describe the progression of chronic kidney disease and diabetic nephropathy, which is treated with multi-component herbal formulas designed to regulate immune and metabolic pathways [10, 15]. In veterinary medicine and aquaculture, the phrase is associated with the "Infectious Spleen and Kidney Necrosis Virus" (ISKNV), a significant double-stranded DNA virus that causes severe organ damage and high mortality in various fish species [1, 5, 17]. Furthermore, these organs are often described as "target organs" for the expression of inducible nitric oxide synthase (iNOS) during conditions like endotoxic shock [2]. Because the provided name refers to an organ pair or a complex disease state rather than a discrete biological molecule, it is not considered a valid canonical therapeutic target in a biotech or drug development context.
Traditional Chinese Medicine (TCM) formulas target multiple proteins (e.g., AKT1, TNF) to 'tonify' these organs and reduce inflammation; in viral contexts, refers to the pathogenesis of systemic organ failure [5, 10, 13].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spleen and kidney.